Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aptamera Inc.

Division of Antisoma PLC
www.aptamera.com

Latest From Aptamera Inc.

Finding the Opportunities in Aptamers

The world is waking up to aptamers. With a few big deals and a small flock of products in the clinic, aptamers' boosters see the molecules largely replacing antibodies; they've got many of the advantages of both large and small molecules, plus the added advantage of speedy creation. But they still face major technological challenges-including high manufacturing costs, limited half-lives, and problems with intracellular targets. The three players whose strategies we profile here-Corgentech, Coley and Archemix--have all chosen to pursue opportunities with aptamers which avoid their biggest problems. But the solutions also limit these companies' abilities to fully exploit the aptamer platform.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Antisoma PLC
  • Senior Management
  • Terry Minton, CEO
    Brian D Brohman, CFO
    Kerry M Barnhart, PhD, CSO
  • Contact Info
  • Aptamera Inc.
    Phone: (502) 587-0939
    640 S. Fourth St.
    Ste. 400
    Louisville, KY 40202
    USA
UsernamePublicRestriction

Register